News

PC providers have knowledge gaps in lung cancer screening


 

FROM A THORACIC ONCOLOGY SYMPOSIUM

References

CHICAGO – Nearly one-fourth of primary care providers were unaware of current lung cancer screening guidelines in a survey of 212 PC providers in North Carolina, a state with one of the nation’s highest lung cancer death rates.

Only 12% of respondents ordered low-dose computed tomography (LDCT) in the past year to screen their patients at high risk for lung cancer, while 21% ordered a chest x-ray, a nonrecommended screening test, said Dr. Jennifer Lewis of Wake Forest University, Winston-Salem, N.C.

Dr. Jennifer Lewis Courtesy of Wake Forest Baptist Health

Dr. Jennifer Lewis

The use of LDCT screening for high-risk patients has been recommended by multiple health care organizations including the American College of Chest Physicians, American Lung Association, and U.S. Preventative Services Task Force. The 2013 USPSTF recommendations call for annual LDCT screening for adults aged 55-80 years who have a 30–pack-year smoking history and currently smoke or have quit within the past 15 years.

The survey found that 67% of providers knew screening was recommended for current and former smokers, but less than half knew the eligible age to initiate screening in any guideline is 50-55 years (35%), the eligible age to stop screening is 75-80 years (29%), and that a 1-year screening interval is recommended (25%).

Only 47% of respondents knew three or more of the guideline components and 24% knew no components.

Providers who knew three or more guideline components, however, were significantly more likely to use LDCT screening (P = .0002), Dr. Lewis said during a briefing at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

The online survey was sent to 488 primary care providers, including physicians, physician assistants, and nurse practitioners, affiliated with Wake Forest Baptist Health. Of the 293 respondents (60%), 212 providers cared for patients older than age 40 years in the past year and were eligible for the study.

Pages

Recommended Reading

Low-dose CT could up early lung cancer detection - at a price
MDedge Family Medicine
FDA approves blood test for membranous glomerulonephritis
MDedge Family Medicine
ASCO and AACR call for stronger e-cigarette regulation
MDedge Family Medicine
AHA wants e-cigarettes regulated but notes they help some smokers quit
MDedge Family Medicine
Majority of cancer patients with depression untreated; integrated collaborative care found ‘strikingly’ effective
MDedge Family Medicine
WHO to push for public ban of e-cigarettes
MDedge Family Medicine
Smokers not so welcome in the house anymore
MDedge Family Medicine
E-cigarettes don’t help cancer patients quit smoking
MDedge Family Medicine
Low-dose CT screen for lung cancer cost effective for high-risk patients
MDedge Family Medicine
CMS proposes lung cancer screening with low-dose CT for high-risk patients
MDedge Family Medicine